NeoPrediX secures funding to drive advancements in neonatal health
scroll south
NeoPrediX, an innovative leader in predictive analytics for neonatal, maternal, and perinatal health, has secured an investment from Springhood Ventures. This new round of funding will accelerate the development of state-of-the-art solutions aimed at enhancing newborn outcomes worldwide.
NeoPrediX develops proprietary algorithms to predict risks of neonatal, maternal, and perinatal health conditions, aiding clinical decision-making with its digital health solutions.Springhood Ventures, a VC firm focused on children's health, supports early-stage companies improving health outcomes in early life. They back entrepreneurs advancing science and technology with strong commercial potential.
This partnership represents a major step forward in their joint mission to enhance neonatal health through innovative, evidence-based technology worldwide.
NeoPrediX participated in Venture Leaders Medtech in 2023.
Neopredix team
NeoPrediX AG: Predictive analytics for neonatal and maternal applications
NeoPrediX develops decision support tools (software-as-a-service) with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We u... Read more
